Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit

Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit
Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit
Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit
Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit

Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit

Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit

Patanjali Ayurved Managing Director Apologizes for Misleading Advertisements in Supreme Court Affidavit

In a significant development, Acharya Balkrishna, the Managing Director of Patanjali Ayurved, has issued an unqualified apology before the Supreme Court over alleged misleading advertisements. The affidavit submitted by Balkrishna expresses regret for breaching the statement recorded in the court’s order dated November 21, 2023, and assures that such misleading advertisements will be avoided in the future.

Regret Over Inadvertent Inclusion of Misleading Statements

Balkrishna’s affidavit acknowledges that the offending sentences in the advertisement were included inadvertently, without the awareness of the court’s order, by the media department of Patanjali Ayurved. He emphasizes that the intention behind the advertisement was solely to promote the consumption of Ayurvedic products for leading a healthier lifestyle, backed by age-old literature and scientific research.

Calls for Modernization of Regulatory Framework

Highlighting the outdated state of Schedule J of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Balkrishna advocates for its modernization in light of advancements in Ayurvedic research. He underscores the need to incorporate evidence-based scientific data into regulatory frameworks to ensure the promotion of holistic and evidence-based solutions for lifestyle-related medical complications.

Response to Contempt Proceedings

Balkrishna’s affidavit responds to the Supreme Court’s earlier order, which sought a response from Patanjali Ayurved in contempt proceedings over alleged misleading advertisements. The court had expressed concerns about the company’s violation of its previous order cautioning against misleading advertisements about its medicines, and had restrained Patanjali Ayurved from making such statements in the media.

Concerns Raised by the Indian Medical Association

The affidavit follows a petition filed by the Indian Medical Association (IMA) seeking guidelines to prohibit false and misleading advertisements related to allopathy and modern medicine. The IMA’s plea aimed to address the issue of misinformation and disparagement against the modern system of medicine, urging strict action against violators of relevant regulations.

Balkrishna’s apology marks a significant step in addressing concerns raised by regulatory authorities and underscores the importance of responsible advertising in promoting public health.

Facebook
Twitter
LinkedIn
Telegram
WhatsApp
Email
Note: You have to fill-up above all respective field, then click below button for send your message